By Counterforce Health Team in Soliris (eculizumab) —

Renewing Soliris (Eculizumab) Coverage with Blue Cross Blue Shield in North Carolina: Complete Timeline and Documentation Guide

Answer Box: Soliris (eculizumab) requires annual reauthorization with Blue Cross Blue Shield of North Carolina. Start renewal 30-60 days before expiration by gathering updated labs (LDH, hemoglobin, platelets), clinical response documentation, and current vaccination records. Submit through Blue e or your specialty pharmacy. If denied, use Smart NC external review—which overturns ~50% of specialty drug denials. First step: check your PA expiration date and call BCBSNC provider services to confirm current criteria.

Table of Contents

  1. Renewal Triggers: When to Start
  2. Evidence Update: What Documentation You Need
  3. Renewal Packet: Must-Include Documents
  4. Timeline: Submission and Decision Windows
  5. If Coverage Lapses: Bridge Options
  6. Annual Changes: What to Re-Verify Each Year
  7. Personal Tracker Template
  8. Common Renewal Denial Reasons & Solutions
  9. Appeals Process for Denied Renewals

Renewal Triggers: When to Start

Blue Cross Blue Shield of North Carolina requires ongoing prior authorization with at least annual clinical review for Soliris (eculizumab). Most approvals are granted for 6-12 months, requiring proactive renewal to avoid treatment gaps.

Signs You Should Start Early

Start 30-60 days before expiration if:

  • Your current approval is for 6 months or less
  • You've had previous denials or appeals
  • Your diagnosis includes multiple indications (PNH with thrombosis, gMG with respiratory involvement)
  • You're switching from another complement inhibitor
  • Your weight has changed significantly (affects dosing calculations)

Start 60-90 days early if:

  • This is your first renewal after initial approval
  • You've had any hospitalizations or ER visits related to your condition
  • Your specialist has changed or you've moved practices
  • You need updated meningococcal vaccinations
Tip: Call Blue Cross NC provider services at the number on your insurance card to confirm your exact PA expiration date and current criteria.

Evidence Update: What Documentation You Need

Successful Soliris renewal requires objective evidence of clinical benefit and ongoing medical necessity. Blue Cross NC's medical drug utilization management program requires documentation of response to therapy.

Core Lab Evidence (All Indications)

For PNH (Paroxysmal Nocturnal Hemoglobinuria):

  • LDH trends showing reduction from baseline
  • Hemoglobin levels and transfusion requirements
  • Reticulocyte count and indirect bilirubin
  • Flow cytometry results (if updated)

For aHUS (Atypical Hemolytic Uremic Syndrome):

  • Platelet count recovery and stabilization
  • Serum creatinine/eGFR improvement
  • LDH reduction indicating decreased hemolysis
  • Dialysis status or plasma exchange requirements

For gMG (Generalized Myasthenia Gravis):

  • MG-ADL (Myasthenia Gravis Activities of Daily Living) scores
  • QMG (Quantitative Myasthenia Gravis) assessment results
  • Exacerbation frequency and hospitalization rates
  • Anti-AChR antibody levels (if retested)

For NMOSD (Neuromyelitis Optica Spectrum Disorder):

  • Relapse frequency and severity documentation
  • MRI findings (if new imaging available)
  • Functional status assessments
  • AQP4-IgG antibody status confirmation

Safety and Compliance Documentation

Required for all renewals:

  • Current meningococcal vaccination records (MenACWY and MenB)
  • Documentation of REMS program compliance
  • Adverse event reporting (or statement of no serious AEs)
  • Confirmation of appropriate dosing and administration schedule

Renewal Packet: Must-Include Documents

Medical Necessity Letter Structure

Your specialist should provide an updated letter of medical necessity that includes:

  1. Current diagnosis confirmation with relevant test results
  2. Treatment history since last approval, including:
    • Baseline vs. current lab values
    • Clinical improvements or stabilization
    • Any breakthrough symptoms or complications
  3. Ongoing medical necessity explaining why Soliris remains the best option
  4. Safety monitoring confirming no contraindications to continued therapy
  5. Alternative therapies and why they're inappropriate or have failed

Essential Supporting Documents

  • Most recent office notes (within 30-90 days) from prescribing specialist
  • Lab results showing response trends over the approval period
  • Vaccination records or updated immunization documentation
  • Hospital records if any admissions occurred during current approval period
  • Pharmacy records confirming adherence and proper administration
Clinician Corner: Use specific numerical improvements in your medical necessity letter. For PNH, cite exact LDH reduction percentages. For gMG, reference MG-ADL score changes. For NMOSD, document relapse-free periods. Quantified improvements strengthen renewal requests significantly.

Timeline: Submission and Decision Windows

Blue Cross NC Processing Times

Request Type Standard Timeline Expedited Timeline Notes
Initial PA Up to 15 business days 72 hours For complete submissions
Renewal PA 10-15 business days 72 hours If no criteria changes
Internal Appeal 30 days 72 hours After denial
External Review (Smart NC) 45 days 72 hours Binding decision

60 days before expiration:

  • Request updated labs and specialist visit
  • Gather vaccination records and pharmacy documentation

45 days before expiration:

  • Specialist completes medical necessity letter
  • Compile complete renewal packet

30 days before expiration:

  • Submit renewal through Blue e portal or designated specialty pharmacy
  • Request expedited review if urgent

15 days before expiration:

  • Follow up on pending decisions
  • Prepare appeal documentation if needed

If Coverage Lapses: Bridge Options

Emergency Authorization Options

Expedited Prior Authorization:

  • Mark requests as "urgent" with clinical justification
  • Document risk of treatment interruption (hemolytic crisis, myasthenic crisis, NMOSD relapse)
  • Include recent labs showing disease activity or instability
  • BCBSNC typically decides within 72 hours for urgent requests

Continuation During Appeal:

  • Request "continuation of therapy pending appeal" in writing
  • Many plans allow 30-60 days of continued coverage during appeals
  • Emphasize documented risk of relapse or deterioration

Bridge Therapy Considerations

For PNH:

  • Optimize supportive care (transfusions, iron chelation, folic acid)
  • Consider ravulizumab (Ultomiris) if covered and appropriate
  • Monitor closely for hemolytic crises requiring emergency intervention

For gMG:

  • IVIG or plasma exchange for acute worsening
  • Optimize cholinesterase inhibitors and immunosuppressants
  • Consider alternative complement inhibitors if available

For NMOSD:

  • High-dose corticosteroids for acute relapses
  • Plasma exchange for steroid-refractory episodes
  • Maintain other preventive therapies
Note: Bridge therapies are temporary measures while pursuing coverage restoration. Work with Alexion Access Navigator (1-888-765-4747) for manufacturer support programs during coverage gaps.

Annual Changes: What to Re-Verify Each Year

Formulary and Policy Updates

Blue Cross NC updates medical drug policies annually, typically effective January 1. Recent policy changes for Soliris include:

For NMOSD: Now requires prior trial and failure of Uplizna (inebilizumab), Enspryng (satralizumab), and ravulizumab before Soliris consideration

For gMG: Prohibits combination with certain newer agents (ravulizumab, rozanolixizumab, efgartigimod, zilucoplan)

For PNH: No dual therapy with other PA-requiring PNH drugs

What to Check Each Renewal Period

  • Current PA criteria through Blue Cross NC provider tools
  • Formulary tier placement and any new restrictions
  • Site of care requirements (home infusion vs. clinic administration)
  • Quantity limits and dosing restrictions
  • Step therapy requirements for your specific indication

Personal Tracker Template

Renewal Checklist

90 Days Before Expiration:

  • Schedule specialist appointment
  • Request updated labs (LDH, CBC, CMP, others as indicated)
  • Check vaccination status and schedule boosters if needed

60 Days Before Expiration:

  • Specialist visit completed with updated medical necessity letter
  • All lab results available and documented
  • Pharmacy records of adherence obtained

30 Days Before Expiration:

  • Complete renewal packet submitted
  • Submission confirmation received
  • Follow-up scheduled with provider office

Decision Received:

  • Approval received with new expiration date
  • OR: Denial received, appeal process initiated
  • Next renewal date added to calendar

Important Contact Numbers

  • Blue Cross NC Provider Services: (Check your provider directory)
  • Alexion Access Navigator: 1-888-765-4747
  • Smart NC External Review: 1-855-408-1212
  • Specialty Pharmacy: (Your designated pharmacy contact)

Common Renewal Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
Insufficient clinical response Provide quantified improvement data Lab trends, symptom scores, hospitalization rates
Missing vaccination records Submit current immunization documentation MenACWY and MenB vaccination dates and types
Alternative therapy not tried Document contraindications or failures Medical records showing intolerance or inadequate response
Off-label use concerns Provide guideline support and specialist rationale Published guidelines, peer-reviewed literature
Dosing outside parameters Justify weight-based or indication-specific dosing Specialist calculation and FDA labeling reference

Appeals Process for Denied Renewals

If your Soliris renewal is denied, North Carolina offers robust appeal rights through the state's external review system.

Internal Appeals (Blue Cross NC)

First Level:

  • Submit within 180 days of denial
  • Include updated medical necessity letter addressing denial reasons
  • Request peer-to-peer review with medical director
  • Decision typically within 30 days

Expedited Appeals:

  • Available when delay poses serious health risk
  • Decision within 72 hours
  • Requires clinical documentation of urgency

External Review (Smart NC)

For eligible state-regulated plans, Smart NC external review provides binding independent review.

Success Rate: Approximately 50% of specialty drug denials are overturned through Smart NC external review, significantly higher than internal appeal success rates.

Eligibility Requirements:

  • North Carolina-regulated health plan (not self-funded ERISA plans)
  • Final internal denial received
  • Request submitted within 120 days of denial
  • Denial based on medical necessity or experimental determination

Process:

  1. Complete external review request form
  2. Submit all denial letters and supporting documentation
  3. Independent Review Organization assigned
  4. Decision within 45 days (72 hours for expedited)
  5. Decision is binding on Blue Cross NC
From our advocates: We've seen many Soliris renewals initially denied for "insufficient documentation" get approved on appeal when specialists provided detailed response data and addressed each denial criterion specifically. The key is thorough documentation that directly counters the plan's stated concerns—not just repeating the original request.

Sources & Further Reading

About Counterforce Health: Counterforce Health helps patients and clinicians navigate complex prior authorization and appeals processes for specialty medications like Soliris. Our platform analyzes denial letters and creates targeted, evidence-backed appeals that significantly improve approval rates for life-saving treatments.

Disclaimer: This guide provides educational information about insurance processes and is not medical advice. Coverage policies vary by plan and change frequently. Always consult your healthcare provider for medical decisions and verify current policy details with your specific Blue Cross Blue Shield plan. For personalized assistance with North Carolina insurance appeals, contact Smart NC at 1-855-408-1212.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.